General

Cell Line
hPSCreg name	AUSCIi001-A
Cite as: When citing this cell line, please use the hPSCreg name (see Naming Tool ) and the corresponding Research Resource ID (RRID).	AUSCIi001-A
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	10th November 2025
User feedback show/hide	Written by on Delete No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Ankara University Stem Cell Institute (AUSCI) Contact: Ankara University Stem Cell Institute (AUSCI)
Owner	Ankara University Stem Cell Institute (AUSCI)
Derivation country	Turkey
External Databases
BioSamples	SAMEA120513855
General Information
* Is the cell line readily obtainable for third parties?	Yes Research use: allowed Clinical use: not allowed Commercial use: not allowed

Donor Information

General Donor Information
Sex	male
Phenotype and Disease related information (Donor)
Diseases	A disease was diagnosed. Spinal muscular atrophy The donor is a carrier of a disease-associated mutation and affected.
Karyotyping (Donor)
Has the donor karyotype been analysed?	Yes 46,XY Karyotyping method: G-Banding
External Databases (Donor)
BioSamples	SAMEA120513856

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived?	Yes
Was the consent voluntarily given?	Yes
Has the donor been informed that participation will not directly influence their personal treatment?	Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor?	No
Do you (Depositor/Provider) hold the original Donor Consent Form?	Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised.	anonymised
Does consent explicitly allow the derivation of pluripotent stem cells?	Yes
* Does consent expressly prevent the derivation of pluripotent stem cells?	No
* Does consent pertain to a specific research project?	No
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world?	No
How may genetic information associated with the cell line be accessed?	Open Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample?	No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions?	Yes
Name of accrediting authority involved?	ANKARA UNIVERSITY FACULTY OF MEDICINE HUMAN RESEARCH ETHICS COMMITTEE
Approval number	I3-109-19
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?

hIPSC Derivation

General
Source cell type	Erythroid progenitor cell
Reprogramming method
Vector type	Non-integrating
Vector	Sendai virus
Is reprogramming vector detectable?	No
Methods used	Immunostaining, PCR, RT-PCR
Files and images showing reprogramming vector expressed or silenced	ipsc.pdf
Vector free reprogramming
Other
Derived under xeno-free conditions	Yes
Derived under GMP?	No
Available as clinical grade?	Unknown

Culture Conditions

Surface coating	Vitronectin
Feeder cells	No
Passage method	Enzymatically Accutase
CO2 Concentration	5 %
Medium	Essential 8™
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?	Yes
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?	No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?	Yes

Characterisation

No characterisation data could be found.

Genotyping

Karyotyping (Cell Line)
Has the cell line karyotype been analysed?	Yes 46,XY Doc2.pdf Passage number: 26 Karyotyping method: G-Banding
Other Genotyping (Cell Line)